home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

7th Modern Drug Discovery & Development Summit

 
  July 08, 2011  
     
 
GTC Conference, Paradise Point Resort & Spa, San Diego, CA
Oct 19-21, 2011



Day 1 - Wednesday, October 19, 2011
10:00aRegistration
 Plenary Keynote Session (4 speakers total)
12:00pBarry A. Morgan Ph.D.
Vice President, Molecular Discovery Research and Site Head 
GlaxoSmithKline, Boston
2:30aNetworking and Refreshment Break
Track Titles5th Biomarker Discovery and Development5th Advances in Stem Cell Discovery and Development5th Drug Design and Medicinal Chemistry4th Protein Design and Therapeutics
3:00Session I:
Novel Technology in Biomarker Discovery
Session I:
Regenerative Medicine & Tissue Engineering
Session I:
Recent Advancements in Hit and Target Identification
Session I:
Bi-specific and Multi-Specific Proteins
5:00pNetworking Reception and Poster Session
  
 Day 2 - Thursday, October 20, 2011
7:00aRegistration and Continental Breakfast
 Four Concurrent Tracks
Track Titles5th Biomarker Discovery and Development5th Advances in Stem Cell Discovery and Development5th Drug Design and Medicinal Chemistry4th Protein Design and Therapeutics
8:00aSession I (cont'd):
Novel Technology in Biomarker Discovery
Session I (cont'd):
Regenerative Medicine & Tissue Engineering
Session I (cont'd):
Recent Advancements in Hit and Target Identification
Session I (cont'd):
Bi-specific and Multi-Specific Proteins
10:00aNetworking and Refreshment Break
10:30aSession II:
Biomarkers & Diagnostics
Session II:
Pre-Clinical & Clinical Trials of Stem Cell Therapy
Session II:
Hit Optimization Strategies
Session II:
Biosimilars and Biosuperiors
12:00pLunch On Your Own
1:30pSession III:
Challenges in Biomarker Development
Session III:
Technology in Stem Cell Research
Session II (cont'd):
Hit Optimization Strategies
Session III:
Fragment-based Drug Discovery
3:00pNetworking and Refreshment Break
3:30pSession III (cont'd):
Challenges in Biomarker Development
Session IV:
Regulatory Aspects and Commercialization
Session III:
Covalent Irreversible Inhibitors: Balancing Potency, Selectivity and Off-Target Activity
Session VI:
The Next Generation of Protein Therapeutics
5:30pCheese and Wine Reception
  
 Day 3 - Friday, October 21, 2011
7:30aContinental Breakfast
 Four Concurrent Tracks
Track Titles5th Biomarker Discovery and Development5th Advances in Stem Cell Discovery and Development5th Drug Design and Medicinal Chemistry4th Protein Design and Therapeutics
8:00aSession IV:
Biomarkers and Translational Biology
Session V:
Induced Pluripotent Cells, Reprogramming & Epigenomics
Session VI:
Approaches for the Early Optimization of Safety in Drug Discovery
Session V:
Advances in Processing: Discovery to Clinical Development
10:00aNetworking and Refreshment Break
10:30aSession V (cont'd):
Biomarkers in Drug Development
Session VI:
Differentiation of Stem Cells
Session VI (cont'd):
Approaches for the Early Optimization of Safety in Drug Discovery
Session V (cont'd):
Advances in Processing: Discovery to Clinical Development
12:30pLunch Provided by GTC
1:30pSession V:
Biomarkers in Drug Development
Session VII:
Stem Cell Applications in Drug Discovery
Session V:
Advances in Drug Delivery
Session VI:
New Developments in Drug Delivery Systems
4:00pConferences Conclude
 
 
Organized by: GTC Conference
Invited Speakers:
Barry A. Morgan Ph.D.
Vice President, Molecular Discovery Research and Site Head 
GlaxoSmithKline, Boston
 

5th Biomarker Discovery & Development Conference
Distinguished Speakers and Scientific Advisory Board Members
 
KEYNOTE SPEAKER
Gary Siuzdak Ph.D.
Director of the Scripps Center for Metabolomics
Professor of Chemistry and Molecular Biology 
The Scripps Research Institute
Faculty Guest 
Lawrence Berkeley National Laboratory
 
 
Wael Al-Delaimy
Associate Professor, Family & Preventive Medicine
Cancer Prevention & Control Program
University of California San Diego
 
Daniel Chelsky
Chief Scientific Officer
Caprion Proteomics
 
Michelle Chen
Director, Translational Medicine
Ventana Medical Systems
 
Brian T. Edmonds
Director, Global External Research & Development
Eli Lilly and Company
 
Jeffrey Fill
Director, CLIA Biomarker Laboratory
Eli Lilly and Company
 
Eric Fung
Senior Vice President and Chief Scientific Officer
Vermillion
 
John Hoey
Scientific Consultant
Integra BioCompliance, LLC
 
Ulrich Hoffmüller
Founder and Chief Business Officer
Epiontis Gmb
 
Jim Karkanias
Senior Director of Applied Research and Technology
Microsoft
 
Paul Kearney, Ph.D.
Co-Founder, President & CSO
Integrated Diagnostics
 
Urban Kiernan
Director, Biomarker Discovery
Intrinsic Bioprobes Inc.
 
 Chris Kinsinger
Program Manager, Clinical Proteomic Technologies for Cancer
NCI/NIH
 
Stephen Pennington
Professor of Proteomics, Conway Institute
University College Dublin
 
Fred Zheng
Research Scientist, Clinical Biomarker Group, Oncology Early Development
AstraZeneca
 
Please check back for updates!
 

The speaker list for the 5th Drug Design & Medicinal Chemistry Conference is not yet available.
 
Please check back for updates!
 

5th Advances in Stem Cell Discovery & Development Conference
Distinguished Speakers
 
Anne Bang, Ph.D.
Director, Cell Biology
Sanford Burham
 
Yen Choo, Ph.D.
Chief Executive Officer
Plasticell Limited
 
Robert Deans
Exec VP of Regenerative Medicine
Athersys
 
Ed Field
Exec VP and Chief Operating Officer
Aldagen
 
Philip Gregory, D.Phil
Chief Scientific Officer
Sangamo Sciences
 
Robert Halliwell
Professor
University of the Pacific
 
Arnaud Lacoste
Project Team Leader
Novartis Institutes for BioMedical Research
 
Huseyin Mehmet
Director, Target Identification & Validation
Merck
 
Mauricio Rojas, M.D.
Assistant Professor
University of Pittsburgh Medical Center
 
Laura Perin
Assistant Professor
Children's Hospital of Los Angeles
 
Please check back for updates!
 

4th Protein Discovery & Therapeutics Conference
Distinguished Speakers and Advisory Board
 
KEYNOTE SPEAKER
William R. Strohl, Ph.D.
Vice President
Biologics Research
Johnson & Johnson
 
 
Chris Bebbington
Vice President, Research
KalosBio
 
Partha Chowdhury
Principal Scientist, Antibody Discovery and Protein Engineering
MedImmune
 
Ed Croze
Director, Translational Research
Bayer Healthcare Pharmaceuticals
 
Dimiter Dimitrov
Head, Protein Interaction Group
NCI, NIH
 
Jeffrey Field
Professor, Pharmacology
University of Pennsylvania
 
Nicolas Fischer
Head, Research
NovImmune SA
 
Patricia Grasso
Associate Professor, Medicine
Albany Medical Center
 
Roman Kischel
Director, Immunotherapy
Micromet AG
 
William McDonald
Group Leader, Protein Sciences
Pfizer
 
Anwar Murtaza
Senior Scientist
Abbott
 
Terrence Town
Endowed Chair in Regenerative Medicine, Maxine Dunitz Neurosurgical Institute
Cedars-Sinai Medical Center
 
Josh Xiao
Principal Scientist, Oncology Discovery
Amgen
 

 
Deadline for Abstracts: Sept. 19,2011
 
Registration: http://www.gtcbio.com/GTCbio_Conference_Registration_Form.pdf
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.